Medical Conferences in China Are Affected by Crackdown on Illegal Behaviors in Pharma Industry
Qian Tongxin
DATE:  Aug 04 2023
/ SOURCE:  Yicai
Medical Conferences in China Are Affected by Crackdown on Illegal Behaviors in Pharma Industry Medical Conferences in China Are Affected by Crackdown on Illegal Behaviors in Pharma Industry

(Yicai) Aug. 4 -- A number of medical academic conferences in China were canceled or delayed as pharmaceutical companies' representatives have been impacted by a nationwide campaign to rectify some illegal behaviors.

Since the crackdown began in late July, the number of medical academic conferences in China has significantly declined as some local governments asked medical staff to return unreasonable remunerations related to the conferences, including the so-called lecture fees.

China recently launched a campaign to investigate several illegal behaviors in the pharmaceutical industry, including pharmaceutical producers, operators, and dealers bribing medical institutes to promote their drugs and public hospitals buying expensive medicines that are not included in the central government bulk-buying auctions or clinical alternative products and carrying out illegal offline purchase.

The Zhejiang Medical Association yesterday announced to delay its 2023 orthopedic academic conference that was initially scheduled for Aug. 10 to Aug. 12. While the association claimed the postponement was to ensure the smooth operation of the 19th Asian Games in Hangzhou, set to be held between Sept. 23 and Oct. 8, an expert told Yicai that the main factor was not the games but the crackdown.

"Zhejiang province has been seriously investigating pharmaceutical representatives, leading to delays in the academic conferences," an industry professional told Yicai. "In one day alone, three of my clients canceled their plans to attend conferences," the person added.

"All procedures have slowed down," a person related to a multinational medical equipment maker told Yicai. "There is a huge pressure when bringing products to hospitals," the person noted, adding that it is uncertain how long the crackdown will last.

The process of bringing products to hospitals is normal, but the number of marketing events has notably dropped, an executive at a Chinese medical apparatus and instruments maker said to Yicai.

Editors: Shi Yi, Futura Costaglione

Follow Yicai Global on
Keywords:   Pharmaceuticals Industry,Medical Industry,Anti-Corruption